In the article titled “Evaluation and Management of Skeletal Health in Celiac Disease: Position Statement” [1], there was an error regarding the FRAX® tool, which should be clarified as follows.
The article notes: “The WHO has developed an absolute fracture risk assessment tool (‘FRAX’) to estimate the 10-year fracture risk in all adults, which is based on the integration of femoral neck bone density, age and other important clinical risk factors .” However, the World Health Organization (WHO) did not develop, test, or endorse the FRAX tool or its recommendations [2]. The metabolic bone disease unit at the University of Sheffield that developed FRAX was a WHO Collaborating Centre from 1991 to 2010. Treatment guidelines must undergo a formal process before they can be endorsed by the WHO.